Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 109 clinical trials
Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant

This phase III trial investigates health informatics and a self-management program for improving the health of cancer survivors after stem cell transplant. After transplant many survivors may feel stressed or may be unsure of what health care they need. A self-management program called "INSPIRE," along with a personalized survivorship care …

remission
cancer
  • 72 views
  • 07 Mar, 2021
  • 16 locations
MNGIE Allogeneic Hematopoietic Stem Cell Transplant Safety Study

The purpose of this study is to find out if a stem cell transplant is safe for patients with a very rare disease. The stem cell transplant is called AHSCT (for "allogeneic hematopoetic stem cell transplantation"). The rare disease is called MNGIE (for "Mitochondrial NeuroGastroIntestinal Encephalomyopathy"). Patients with MNGIE will …

  • 12 views
  • 23 Jan, 2021
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

Background GATA2 deficiency is a disease caused by mutations in the GATA2 gene. It can cause different types of leukemia and other diseases. Researchers want to see if a stem cell transplant can be used to treat this condition. A stem cell transplant will give stem cells from a matching …

malignant disease
ejection fraction
busulfan
bone marrow procedure
conjugated bilirubin
  • 26 views
  • 28 Jan, 2021
  • 1 location
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies

This is a standard of care treatment guideline for allogeneic hematopoetic stem cell transplant (HSCT) in patients with primary immune deficiencies.

undernutrition
treatment guideline
melphalan
x-linked lymphoproliferative disease
cell transplantation
  • 265 views
  • 27 Jan, 2021
  • 1 location
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

This is a treatment guideline for a second or greater allogeneic hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) in patients with non-malignant or

g-csf
fludarabine
myeloablative conditioning
stem cell transplantation
busulfan
  • 17 views
  • 24 Jan, 2021
  • 1 location
Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases

Background During a transplant, blood stem cells from one person are given to someone else. The cells grow into the different cells that make up the immune system. This can cure people with certain immunodeficiencies. But transplant has many risks and complications. Objective To see if stem cell transplant can …

busulfan
ejection fraction
pulmonary function tests
bone marrow procedure
schwartz
  • 0 views
  • 19 Feb, 2021
  • 1 location
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

This is a Phase II study of allogeneic hematopoietic stem cell transplant (HCT) using a myeloablative preparative regimen (of either total body irradiation (TBI); or, fludarabine/busulfan for

blood cell count
chronic lymphocytic leukemia
lymphoid leukemia
adult t-cell leukemia/lymphoma
ejection fraction
  • 58 views
  • 27 Jan, 2021
  • 1 location
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia

Fludarabine-based preparative regimen followed by an allogeneic hematopoietic stem cell transplant using related or unrelated donor in persons 0-70 years of age diagnosed with dyskeratosis

pancytopenia
severe aplastic anemia
ejection fraction
aplastic anemia
erythropoietin
  • 24 views
  • 25 Jan, 2021
  • 1 location
Study of Iomab-B vs. Conventional Care in Older Subjects With Active Relapsed or Refractory Acute Myeloid Leukemia

stem cell transplant (HCT), versus Conventional Care in patients with Active, Relapsed or Refractory Acute Myeloid Leukemia (AML).

refractory acute myeloid leukemia (aml)
hydroxyurea
myeloid leukemia
myeloablative conditioning
stem cell transplantation
  • 0 views
  • 28 Jan, 2021
  • 22 locations
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

The investigators primary objective is to determine the safety and toxicity of incorporating blinatumomab into the post-allogeneic hematopoietic stem cell transplant (HSCT) maintenance setting

blood cell count
lymphoid leukemia
lymphoma
hodgkin's disease
flow cytometry
  • 4 views
  • 25 Jan, 2021
  • 1 location